After yesterday's decline, the three major U.S. futures indexes rose slightly before Thursday, reflecting the swing mood of the market in uncertainty, and U.S. bond yields resumed their rise.
Daniel Morris, chief market strategy analyst of France Pakistan asset management, said that before February this year, we were worried about raising interest rates, and then concerns about military conflict flooded the market. Now these two problems are intertwined. The challenge of the current environment is that you can't hold cash, which is the so-called choosing the less bad ones from a pile of bad targets.
It is worth noting that Biden, who has been shouting outside the Russian Ukrainian conflict line, also personally entered Europe on Thursday. After today's meeting with EU, NATO and G7 leaders, Biden will also visit Poland near Ukraine on Friday. Western countries are expected to take this opportunity to continue to put pressure on Russia, but there is also limited room for Europe to make concessions on the most critical energy issues.
market dynamics
The Beijing standard & Poor's futures index (SPX) rose by 30.0% as of June 2, with the Dow futures index rising by 20.00%; Nasdaq 100 index futures rose 0.49%.
On the previous trading day, the three major stock indexes opened low and went low, with a decline of more than 1%. As of the close, the S & P 500 index fell 1.23% to 445624; The NASDAQ index fell 1.32% to 1392260; The Dow Jones index fell 1.29% to 3435850.
In the context of inflation and higher treasury bond yields, the European market under trading is generally weak, and market sentiment is in a wait-and-see state.
(European market trend on Thursday, source: Investing)
company information
[Nikolay motors increased by 16% before starting to produce electric trucks]
After Wednesday's session, Nikolay automobile announced that it had begun to produce electric semi-trailer trucks in American factories this week, and delivery is expected to start in the second quarter. The annual output is expected to be less than Tus-Design Group Co.Ltd(300500) . Affected by this message. As of press time, the company rose 16.19% before trading.
[Qualcomm's $4.5 billion acquisition of veoneer will be completed next week]
Veoneer, a Swedish automotive technology company, said in a statement on Thursday that the $4.5 billion acquisition of the company by Qualcomm joint investment agency SSW partners will be completed on April 1, when the new boss will replace the company's CEO.
[Hertz car rental includes model y in the optional range]
According to local media reports, Hertz, a car rental platform, has included Tesla Model y into the customer's optional range, which is also the latest progress after the company announced the purchase of 100000 Tesla a a few months ago. It is worth mentioning that musk previously responded that the company did not sign an agreement with Hertz and did not provide car discounts.
[Moderna raises the annual sales forecast of covid-19 vaccine]
On Thursday, local time, the biopharmaceutical company Moderna announced that it would raise the covid-19 vaccine sales guidance in fiscal year 2022 from US $19 billion to US $21 billion, and the additional sales are expected to increase from US $3 billion to US $5 billion.
[Jingke energy: orders are full this year, with a significant increase compared with last year]
Qian Jing, vice president of Jingke energy, said that after this year, the order volume is very strong, with a significant increase compared with the same period last year, especially from China, Asia Pacific, Europe, Latin America and the Middle East, the financial Associated Press reported on Thursday. This is mainly affected by various countries' double carbon targets, energy and power shortages, soaring oil and gas prices and other factors.
[FDA does not approve Lilly / Cinda biological lung cancer new drug listing application]
Cinda biology announced on Thursday that the company received a complete reply from the U.S. Food and Drug Administration (FDA) on the new drug marketing application (BLA) of cindilimab combined with pemetrexed and platinum chemotherapy for first-line treatment of patients with non-squamous non-small cell lung cancer (NSCLC).
FDA said in its reply that it had completed the review of the BLA, but failed to approve the application, which was consistent with the results of the previous meeting of the oncology drug advisory committee (ODAC) held in February. The response letter included a proposal for an additional clinical study, suggesting that Xindi case monoclonal antibody combined with chemotherapy and the standard treatment of first-line metastatic NSCLC should conduct a multi regional non inferiority clinical trial with the end point of overall survival. The company is working with Eli Lilly to evaluate the next step of cindizumab in the United States.
events worthy of attention during US equities (Beijing time)
March 24
At 21:00, the Bank of South Africa announced the interest rate resolution
21:10 Federal Reserve governor Waller discusses the housing market
21:50 Chicago Fed chairman Evans delivered a speech
23:00 Atlanta Fed chairman Bostick delivered a speech
To be determined, US President Biden will attend the NATO special summit, the European Council Summit and the G7 leaders' meeting
March 25
03:00 Mexico to March 24 central bank interest rate decision
04:30 to the week of March 19, foreign central banks held us treasury bonds
